BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30486609)

  • 1. CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis.
    Ibrahim A; Zahran AM; Aly SS; Refaat A; Hassan MH
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3187-3192. PubMed ID: 30486609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients.
    Pluta A; Wrzesien-Kus A; Cebula-Obrzut B; Wolska A; Szmigielska-Kaplon A; Czemerska M; Pluta P; Robak T; Smolewski P; Wierzbowska A
    Leuk Res; 2010 Oct; 34(10):1308-13. PubMed ID: 20061022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
    Mizutani Y; Katsuoka Y; Bonavida B
    Int J Oncol; 2010 Aug; 37(2):503-8. PubMed ID: 20596678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia.
    Djunic I; Virijevic M; Djurasinovic V; Novkovic A; Colovic N; Kraguljac-Kurtovic N; Vidovic A; Suvajdzic-Vukovic N; Tomin D
    Med Oncol; 2012 Sep; 29(3):2077-82. PubMed ID: 22081445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0.
    Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T
    Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy.
    Hu XM; Liu F; Zheng CM; Li L; Liu C; Zhang SS; Xiao HY; Yang XH; Wang HZ; Xu YG; Hu NP; Ma R
    Chin J Integr Med; 2009 Jun; 15(3):193-7. PubMed ID: 19568712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression levels of the mitochondrial IAP antagonists Smac/DIABLO and Omi/HtrA2 in clear-cell renal cell carcinomas and their prognostic value.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    J Cancer Res Clin Oncol; 2008 May; 134(5):543-50. PubMed ID: 17922292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Bcl2 protein predicts chemoresistance in acute myeloid leukemia: its correlation with FLT3.
    Mehta SV; Shukla SN; Vora HH
    Neoplasma; 2013; 60(6):666-75. PubMed ID: 23906301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients.
    Pluta P; Cebula-Obrzut B; Ehemann V; Pluta A; Wierzbowska A; Piekarski J; Bilski A; Nejc D; Kordek R; Robak T; Smolewski P; Jeziorski A
    Neoplasma; 2011; 58(5):430-5. PubMed ID: 21744997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of CD7 and CD56 antigens in acute leukaemias.
    Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
    Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients.
    Pluta A; Robak T; Cebula B; Majchrzak A; Pluta P; Brzozowski K; Stępka K; Szmigielska-Kapłon A; Grzybowska-Izydorczyk O; Czemerska M; Smolewski P; Wierzbowska A
    Arch Med Sci; 2021; 17(3):700-707. PubMed ID: 34025840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis repressor with caspase recruitment domain modulates second mitochondrial-derived activator of caspases mimetic-induced cell death through BIRC2/MAP3K14 signalling in acute myeloid leukaemia.
    Mak PY; Mak DH; Ruvolo V; Jacamo R; Kornblau SM; Kantarjian H; Andreeff M; Carter BZ
    Br J Haematol; 2014 Nov; 167(3):376-84. PubMed ID: 25079338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of CD11b and CD56 expression in adult acute myeloid leukemia with cytogenetic risk groups and prognosis.
    Juncà J; Garcia-Caro M; Granada I; Rodríguez-Hernández I; Torrent A; Morgades M; Ribera JM; Millá F; Feliu E
    Ann Hematol; 2014 Sep; 93(9):1483-9. PubMed ID: 24782118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents.
    Carter BZ; Mak PY; Mak DH; Shi Y; Qiu Y; Bogenberger JM; Mu H; Tibes R; Yao H; Coombes KR; Jacamo RO; McQueen T; Kornblau SM; Andreeff M
    J Natl Cancer Inst; 2014 Feb; 106(2):djt440. PubMed ID: 24526787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.
    Wang H; Liu YC; Zhu CY; Yan F; Wang MZ; Chen XS; Wang XK; Pang BX; Li YH; Liu DH; Gao CJ; Liu SJ; Dou LP
    J Exp Clin Cancer Res; 2020 Dec; 39(1):278. PubMed ID: 33298132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapeutic Resistance in Egyptian Acute Myeloid Leukemia Patients.
    Kassem NM; Medhat N; Kassem HA; El-Desouky MA
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2421-2427. PubMed ID: 31450916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
    Chen C; Chio CL; Zeng H; Li Y
    Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
    Dobrzycka B; Terlikowski SJ; Bernaczyk PS; Garbowicz M; Niklinski J; Chyczewski L; Kulikowski M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):678-81. PubMed ID: 21478115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.